Sarepta Therapeutics Inc (NASDAQ:SRPT) - Share price - Overview

Stock Report

Sarepta Therapeutics Inc SRPT

Last Price
$88.96

Day Change
-0.26|-0.29%

As of 23/05/2018
19:52:55 EDT | USD
Minimum 15 Minutes Delay.

Last Close89.22
Day Range86.55 - 90.84
Mkt Cap5.83Bil
52-Wk Range28.82 - 95.67
Yield %-
ISINUS8036071004
Volume1,231,917
P/E-30.26
P/S26.88
P/CF-25.98

Share Price

Financials
201520162017
More ...
Income Statement
Revenue1.255.42154.58
Operating Income-220.18-264.18-140.38
Net Income-220.03-267.27-50.69
Basic EPS-5.20-5.49-0.86
Avg. Diluted Shares Outstanding424959
Balance Sheet
Current Assets224.54373.481,228.64
Non Current Assets49.2450.6379.32
Total Assets273.78424.101,307.96
Current Liabilities62.2975.4288.33
Total Liabilities---
Total Equity190.35336.69789.22
Cash Flow
Operating Cash Flow-149.47-245.82-232.00
Capital Expenditure-4.83-6.87-21.22
Free Cash Flow-154.30-252.69-253.21

In millions, except "Basic EPS". Currency is USD.

Company Profile

Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

255
Key Stats
More ...
Price/Earning TTM-30.35
Price/Book7.53
Price/Sales TTM33.95
Rev Growth (3 year avg)151.16
EPS Growth (3 year avg)-
Operating Margin % TTM-90.81
Net Margin % TTM-32.79
ROE TTM-9.00
Debt/Equity0.54
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.